Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02867592
Title Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications

renal cell carcinoma

central nervous system cancer

thyroid gland medullary carcinoma

sarcoma

Advanced Solid Tumor

adrenal cortex cancer

renal Wilms' tumor

Ewing sarcoma

clear cell sarcoma

hepatocellular carcinoma

hepatoblastoma

rhabdomyosarcoma

alveolar soft part sarcoma

Therapies

Cabozantinib

Age Groups: adult | child
Covered Countries USA

Additional content available in CKB BOOST